Qing Ni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qing Ni has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Shan Zhang
2 shared publicationsBingrong Wu
Department of Endocrinology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China
1 shared publicationJun-Li Liu
1 shared publicationMao-Ying Wei
1 shared publicationQian Wu
1 shared publicationQing Pang
1 shared publication
Latest Publications
- 15 June 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 17 (6)
Shenqi Jiangtang Granules attenuate ferroptosis in diabetic cardiomyopathy via the dihydroorotate dehydrogenase-coenzyme Q pathway
BACKGROUND Shenqi Jiangtang Granules (SQJT), a traditional Chinese patent medicine, have long been prescribed for type II diabetes mellitus. Increasing evidence suggests that SQJT has cardioprotective effects; however, its mechanisms in diabetic cardiomyopathy (DCM), particularly regarding ferroptosis, remain unclear. We hypothesized that SQJT protects against DCM by inhibiting ferroptosis via the dihydroorotate dehydrogenase (DHODH)/coenzyme Q (CoQ) signaling pathway. AIM To elucidate the mechanism through which SQJT attenuates ferroptosis in DCM. METHODS Active constituents of SQJT were obtained from previous mass spectrometry analyses. Potential targets were predicted using network pharmacology, protein-protein interaction, molecular docking, and dynamics simulation. Cell viability, death, and ferroptosis markers were assessed in high glucose/lipid-induced H9C2 cells. Intracellular iron, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), glutathione (GSH), and reactive oxygen species (ROS) levels were measured, and mitochondrial morphology was examined by MitoTracker staining. The expression of DHODH/CoQ pathway components was analyzed by reverse transcription-quantitative PCR and Western blotting, and pathway dependence was confirmed using the DHODH inhibitor brequinar (BRQ). RESULTS The SQJT-DCM-ferroptosis network identified 16 intersecting targets, with DHODH as the primary candidate. SQJT significantly improved cell viability and attenuated ferroptosis. Specifically, treatment with 6% SQJT reduced intracellular free iron levels by 61.8% and lipid peroxidation (MDA) levels by 55.9% (all P < 0.001). Furthermore, SQJT restored antioxidant enzyme activities (SOD and GSH-PX) by over 100%, while maintaining mitochondrial membrane integrity and reducing the proportion of ROS-positive cells from 51.6% to 11.8%. These protective effects, mediated via the DHODH/CoQ signaling axis, were significantly abolished by BRQ. CONCLUSION SQJT alleviates ferroptosis and oxidative stress, potentially through modulation of the DHODH/CoQ pathway, while preserving mitochondrial integrity and enhancing cardiomyocyte survival, suggesting its therapeutic potential in DCM. However, the mechanistic findings were based on pharmacological inhibition rather than genetic validation. Therefore, further genetic and in vivo studies are needed.
- 15 June 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 17 (6)
Shenqi Jiangtang Granules attenuate ferroptosis in diabetic cardiomyopathy via the dihydroorotate dehydrogenase-coenzyme Q pathway
BACKGROUND Shenqi Jiangtang Granules (SQJT), a traditional Chinese patent medicine, have long been prescribed for type II diabetes mellitus. Increasing evidence suggests that SQJT has cardioprotective effects; however, its mechanisms in diabetic cardiomyopathy (DCM), particularly regarding ferroptosis, remain unclear. We hypothesized that SQJT protects against DCM by inhibiting ferroptosis via the dihydroorotate dehydrogenase (DHODH)/coenzyme Q (CoQ) signaling pathway. AIM To elucidate the mechanism through which SQJT attenuates ferroptosis in DCM. METHODS Active constituents of SQJT were obtained from previous mass spectrometry analyses. Potential targets were predicted using network pharmacology, protein-protein interaction, molecular docking, and dynamics simulation. Cell viability, death, and ferroptosis markers were assessed in high glucose/lipid-induced H9C2 cells. Intracellular iron, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), glutathione (GSH), and reactive oxygen species (ROS) levels were measured, and mitochondrial morphology was examined by MitoTracker staining. The expression of DHODH/CoQ pathway components was analyzed by reverse transcription-quantitative PCR and Western blotting, and pathway dependence was confirmed using the DHODH inhibitor brequinar (BRQ). RESULTS The SQJT-DCM-ferroptosis network identified 16 intersecting targets, with DHODH as the primary candidate. SQJT significantly improved cell viability and attenuated ferroptosis. Specifically, treatment with 6% SQJT reduced intracellular free iron levels by 61.8% and lipid peroxidation (MDA) levels by 55.9% (all P < 0.001). Furthermore, SQJT restored antioxidant enzyme activities (SOD and GSH-PX) by over 100%, while maintaining mitochondrial membrane integrity and reducing the proportion of ROS-positive cells from 51.6% to 11.8%. These protective effects, mediated via the DHODH/CoQ signaling axis, were significantly abolished by BRQ. CONCLUSION SQJT alleviates ferroptosis and oxidative stress, potentially through modulation of the DHODH/CoQ pathway, while preserving mitochondrial integrity and enhancing cardiomyocyte survival, suggesting its therapeutic potential in DCM. However, the mechanistic findings were based on pharmacological inhibition rather than genetic validation. Therefore, further genetic and in vivo studies are needed.
- Open Access
- 28 August 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 191, 118499
The molecular mechanisms of disulfidptosis and its role in Diabetes mellitus and its complications
- 28 August 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 191, 118499
Open AccessThe molecular mechanisms of disulfidptosis and its role in Diabetes mellitus and its complications
- Open Access
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1557923
Global burden of Type 2 Diabetes Mellitus attributable to dietary risks in elderly adults: insights from the Global Burden of Disease study 2021
Background: Type 2 Diabetes Mellitus (T2DM) poses a significant global health challenge, particularly among elderly adults. Dietary risk factors, such as high consumption of processed meats and sugar-sweetened beverages and low intake of whole grains and fruits, play a critical role in the burden of T2DM. This study aims to comprehensively quantify the global burden of T2DM attributable to dietary risks among elderly adults, identify significant dietary risk factors driving disease burden, and evaluate temporal, regional, and demographic variations to inform targeted public health strategies and interventions for reducing the impact of T2DM.Methods: This study utilized data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to assess T2DM burden attributable to dietary risks among adults aged 65 years and older across 204 countries and territories. Metrics included age-standardized mortality rates (ASMR) and disability-adjusted life-year rates (ASDR). Dietary risk factors analyzed included low intake of whole grains, fruits, vegetables, and fiber, as well as high intake of processed meat, red meat, and sugar-sweetened beverages. Joinpoint regression and decomposition analyses were performed to examine temporal trends and drivers of changes by region, SDI level, sex, and age.Results: In 2021, dietary risks accounted for 23.61% of T2DM-related deaths and 24.85% of DALYs among elderly adults. ASMR showed a slight decline globally (AAPC: −0.08), while ASDR exhibited a significant upward trend (AAPC: +0.7) from 1990 to 2021. High SDI regions demonstrated decreasing ASMR but persistent DALYs due to prolonged survival with complications. Conversely, low and middle SDI regions exhibited rapid increases in ASMR and ASDR, driven by dietary transitions and limited healthcare resources. Males consistently bore a higher burden than females, with pronounced disparities in low and middle SDI regions. Aging and population growth were the primary drivers of the increasing burden globally.Conclusion: This study underscores the substantial burden of T2DM attributable to dietary risks among elderly adults and highlights significant regional and demographic disparities. Targeted public health interventions, personalized nutritional strategies, and improved healthcare access are essential to mitigate this burden. Future research should explore the impact of emerging dietary trends and precision nutrition on T2DM prevention and management.
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1557923
Open AccessGlobal burden of Type 2 Diabetes Mellitus attributable to dietary risks in elderly adults: insights from the Global Burden of Disease study 2021
Background: Type 2 Diabetes Mellitus (T2DM) poses a significant global health challenge, particularly among elderly adults. Dietary risk factors, such as high consumption of processed meats and sugar-sweetened beverages and low intake of whole grains and fruits, play a critical role in the burden of T2DM. This study aims to comprehensively quantify the global burden of T2DM attributable to dietary risks among elderly adults, identify significant dietary risk factors driving disease burden, and evaluate temporal, regional, and demographic variations to inform targeted public health strategies and interventions for reducing the impact of T2DM.Methods: This study utilized data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to assess T2DM burden attributable to dietary risks among adults aged 65 years and older across 204 countries and territories. Metrics included age-standardized mortality rates (ASMR) and disability-adjusted life-year rates (ASDR). Dietary risk factors analyzed included low intake of whole grains, fruits, vegetables, and fiber, as well as high intake of processed meat, red meat, and sugar-sweetened beverages. Joinpoint regression and decomposition analyses were performed to examine temporal trends and drivers of changes by region, SDI level, sex, and age.Results: In 2021, dietary risks accounted for 23.61% of T2DM-related deaths and 24.85% of DALYs among elderly adults. ASMR showed a slight decline globally (AAPC: −0.08), while ASDR exhibited a significant upward trend (AAPC: +0.7) from 1990 to 2021. High SDI regions demonstrated decreasing ASMR but persistent DALYs due to prolonged survival with complications. Conversely, low and middle SDI regions exhibited rapid increases in ASMR and ASDR, driven by dietary transitions and limited healthcare resources. Males consistently bore a higher burden than females, with pronounced disparities in low and middle SDI regions. Aging and population growth were the primary drivers of the increasing burden globally.Conclusion: This study underscores the substantial burden of T2DM attributable to dietary risks among elderly adults and highlights significant regional and demographic disparities. Targeted public health interventions, personalized nutritional strategies, and improved healthcare access are essential to mitigate this burden. Future research should explore the impact of emerging dietary trends and precision nutrition on T2DM prevention and management.